Craneware completes $25m share buyback and updates capital structure

Craneware ( (GB:CRW) ) has shared an announcement.

Craneware has completed a $25m share buyback programme initiated in March 2026, repurchasing a total of 1,276,957 ordinary shares, including 43,134 shares bought on 12 May at a volume-weighted average price of 1,501.21p. All repurchased shares are being held in treasury, primarily to satisfy existing share options and long-term incentive plans, leaving 34,237,148 shares in issue and setting a new base for voting rights calculations under FCA rules.

By retiring the shares into treasury rather than cancelling them, Craneware preserves flexibility to meet employee equity commitments without diluting current shareholders in future. The completed buyback also signals management’s confidence in the company’s valuation and cash generation, while modestly enhancing earnings per share and clarifying the company’s capital structure for investors and regulators.

Spark’s Take on CRW Stock

According to Spark, TipRanks’ AI Analyst, CRW is a Neutral.

The score is driven primarily by solid financial performance (strong margins and a low-debt balance sheet), but it is meaningfully weighed down by weak technical momentum (price below key moving averages with negative MACD) and a relatively high P/E that limits valuation support despite the dividend yield.

To see Spark’s full report on CRW stock, click here.

More about Craneware

Craneware plc is a healthcare technology company specialising in financial and operational performance solutions for hospitals and healthcare organisations. Its cloud-based Trisus platform integrates revenue intelligence, margin intelligence and advanced analytics to help providers optimise financial sustainability and support long-term strategic growth.

Average Trading Volume: 250,755

Technical Sentiment Signal: Sell

Current Market Cap: £527.4M

See more insights into CRW stock on TipRanks’ Stock Analysis page.